Administration of the PARP Inhibitor Pj34 Ameliorates the Impaired Vascular Function Associated With Enos−/− Mice

Placenta/birthweight ratio and perinatal outcome: a retrospective cohort analysis

(2011) F Shehata et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Role of nitric oxide in placental vascular development and function

(2011) B.J. Krause et al.   PLACENTA

Vascular Dysfunction in Women With a History of Preeclampsia and Intrauterine Growth Restriction

(2010) Yoav Yinon et al.   CIRCULATION

Intrauterine growth restriction and placental angiogenesis

(2010) Figen Barut et al.   Diagnostic Pathology

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

(2009) Csaba Szabo   BRITISH JOURNAL OF PHARMACOLOGY

In Vitro Assessment of Mouse Uterine and Fetoplacental Vascular Function

(2009) L.C. Kusinski et al.   Reproductive Sciences

eNOS, metabolic syndrome and cardiovascular disease

(2009) Paul L. Huang   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease

(2008) Pal Pacher et al.   AMERICAN JOURNAL OF PATHOLOGY

Gross morphological changes of placentas associated with intrauterine growth restriction of fetuses: A case control study

(2008) Sharmistha Biswas et al.   EARLY HUMAN DEVELOPMENT